Skip to content
Trial Eligibility
Menu

Anxiety During Abstinence in AUD

NCT06793488

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to better understand the underlying neurobiological basis of anxiety that emerges during abstinence in patients with alcohol use disorder (AUD). The main questions it aims to answer are: To characterize anxiety itself as well as anxiety related-neurobiological circuitry in early abstinence in AUD To examine how anxiety and anxiety related-neurobiological circuitry change over the course of abstinence in AUD Researchers will recruit both participants with AUD and healthy volunteers.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alcohol Use Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
21 to 55 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
February 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University Irving Medical Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.